<?xml version="1.0" encoding="UTF-8"?>
<p id="P96">
 <bold>Telaprevir.</bold> Telaprevir is an orally available inhibitor specific to the HCV nonstructural 3/4A serine protease.
 <sup>
  <xref ref-type="bibr" rid="R197">197</xref>
 </sup> It inhibits HCV replication by binding reversibly to nonstructural 3 serine protease. After oral administration, telaprevir achieves peak plasma concentrations in 4 to 5 hours. It is metabolized primarily in the liver and it has an elimination half-life of 4 to 5 hours. Most of the drug is excreted in the feces.
</p>
